Active Lipid Management In Coronary Artery Disease (ALMICAD) Study

American Journal of Medicine

Volumn 120, Issue 8, 2007, Pages

  Khanal, Sanjaya ^a   Obeidat, Omar ^a   Hudson, Michael P ^a   Al Mallah, Mouaz ^a   Bloome, Mary ^a   Lu, Mei ^a   Greenbaum, Adam B ^a   Kugelmass, Aaron D ^a   Weaver, W Douglas ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Lipid clinic; Outcomes; Secondary prevention

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STROKE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ALANINE TRANSAMINASE; ALGORITHMS; AMBULATORY CARE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 34547424950     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.06.048     Document Type: Article

References (15)

1. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
2. Shepherd J., Cobbe S.M., Ford I., et al., West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 (1995) 1301-1307
3. Downs J.R., Clearfield M., Weis S., et al., AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 279 (1998) 1615-1622
4. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 44 (1994) 1383-1389
5. Sacks F.M., Pfeffer M.A., Moye L., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
6. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Eng J Med 339 (1998) 1349-1357
7. Cannon C.P., Braumwald E., McCabe C.H., et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction-22. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
8. Yusuf S., and Anand S. Cost of prevention: the case of lipid lowering. Circulation 93 (1996) 1774-1776
9. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
10. Pearson T.A., Laurora I., Chu H., and Kafonek S. The lipid treatment assessment project- a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
11. Marcello J.J., and Feingold K. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med 100 (1996) 605-610
12. Grundy S.M., Cleeman J.I., Merz N.B., et al., Coordinating Committee of the National Cholesterol Education Program. Implications of the recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44 (2004) 720-732
13. Bloome M., Saier R., Bronken T., and Zarowitz B. Tele health attainment of lipid goals through automated workflow technology. Pharmacotherapy 20 (2000) 1259
14. Harris D.E., Record N.B., Gipson G.W., and Pearson T.A. Lipid lowering in a multidisciplinary clinic compared with primary physician management. Am J Cardiol 81 (1998) 929
15. Koren M.J., Hunninghake D.B., and ALLIANCE Study investigators. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics. J Am Coll Cardiol 44 (2004) 1772-1779